Mary Albertson’s Post

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/G5FC50Spl4A

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/nhFj50Syc3C

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/nhFj50Syc3C

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/G5FC50Spl4A

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/Toq350SwXIk

Discover how using specific T cell subtypes as starting material can significantly improve CAR-T manufacturing. This article highlights the advantages of naive T cells and T memory stem cells, showing how these cells lead to enhanced efficacy and safety in CAR-T therapies. Curious to learn more about optimizing your CAR-T processes with these insights? Dive into the full article now! https://lnkd.in/g8-xN2nB #OCBio, #OrangeCountyBio, #CGT, #CellandGeneTherapy, #CellTherapy, #GeneTherapy, #Consulting, #Marketing

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/Toq350SwXIk

"We have developed a five-year strategy focusing on Ncardia’s strengths with the aim of becoming a world leader in stem cell applications. Our main purpose is to develop a focused portfolio of high-quality cells and ready-to-use assays for drug discovery, as well as manufacturing processes for cell supply and regenerative medicine applications. In the coming years, our company will establish and expand on these areas, utilizing proprietary technology and expertise developed over the past decade." Insightful interview with Dr. Jeroen De Groot, reflecting on his first 6 months as Divisional CEO of Ncardia! The conversation with him covered questions like: 🔶 2023 was an exciting year for Ncardia, what has changed and what's to come in the next five years? 🔶 What makes Ncardia unique? 🔶 How does Ncardia support drug and cell therapy developers? 🔶 Ncardia prides itself on being an all-around, long-term partner for drug discovery. How do you work with clients? 🔶 What are the most exciting current developments at Ncardia? Check out the full interview below (link in the comments) ⬇ #drugdiscovery #celltherapy #ipsc

It's an incredibly exciting time in the world of pluripotent stem cell (PSC) research and manufacturing. These advances are, of course, essential to the future of PSC applications across the fields of drug discovery and development, cellular therapeutics, personalized medicine, and beyond. "Pluripotent stem cell banking with a closed, automated, and GMP-compliant system": Establishment of PSC banks, including master cell banks and working cell banks, by expanding cells in a GMP-compliant environment is a vital step during the manufacturing processes of PSC-based cell therapies. The CliniMACS Prodigy Adherent Cell Culture process offers nine modules representing different workflow steps, such as coating, inoculation, culture, media change, and harvest, during cell manufacturing. These modules can be flexibly combined to automate the PSC expansion process while the GMP-compliant, single-use CliniMACS Prodigy Tubing Set 730 provides a closed and sterile environment for PSC cultures. External culture vessels can also easily be connected to extend manufacturing scalability, highlighting the CliniMACS Prodigy as a ready-to-use solution for GMP-compliant PSC banking. Learn more at: https://lnkd.in/g4K_ZwNV #cellculture #cellmanufacturing #stemcells #ipscells Miltenyi Biotec Friederike Fassbender Isabelle Haake

We are so excited to announce our new partnership with growth factor manufacturer, Qkine! This collaboration will combine the expertise in complex protein manufacturing and engineering of Qkine with StemCultures, LLC. proprietary controlled-release technologies to develop new reagents for precision stem cell expansion and differentiation. "We are beginning to tackle the complexities of stem cell culture, where growth factors—proteins that provide essential signals to stem cells—degrade at varying rates, are inhibited by natural inhibitors accumulating in the culture, and are sequestered, leading to a fundamental lack of control over culture conditions. This lack of control affects the quality of data and scalability for disease models and the development of cell therapies." Dr. Catherine Elton, CEO and Founder of Qkine. #stemcells #organoids #growthfactors